Business · 23/09/2014
FDA to Host Public Meeting on Abuse-Deterrent Opioid Medications
The US Food and Drug Administration (FDA) is hosting a public meeting to gather input from various stakeholders on the development, assessment, and regulation of abuse-deterrent formulations of opioid medications, with a focus on their scientific and technical aspects.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →